| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.49e-08 | 303 | 31 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | MED15 SMARCA2 SMARCC1 KMT2C TSC22D1 KMT2D MAML3 MED12 NOTCH1 | 1.21e-07 | 562 | 31 | 9 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin binding | 1.25e-05 | 739 | 31 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED15 SMARCA2 SMARCC1 KMT2C TSC22D1 KMT2D MAML3 MED12 NOTCH1 | 4.60e-05 | 1160 | 31 | 9 | GO:0030674 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 6.49e-05 | 8 | 31 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 9.36e-05 | 1271 | 31 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.04e-04 | 10 | 31 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED15 SMARCA2 SMARCC1 KMT2C TSC22D1 KMT2D MAML3 MED12 NOTCH1 | 1.54e-04 | 1356 | 31 | 9 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.36e-04 | 20 | 31 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 4.82e-04 | 1244 | 31 | 8 | GO:0000978 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.11e-03 | 1412 | 31 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.20e-03 | 33 | 31 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.38e-03 | 1459 | 31 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.58e-03 | 560 | 31 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.66e-03 | 566 | 31 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.12e-03 | 44 | 31 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.00e-03 | 187 | 31 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.78e-03 | 417 | 31 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 4.32e-03 | 213 | 31 | 3 | GO:0008168 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 4.97e-03 | 224 | 31 | 3 | GO:0016741 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.99e-03 | 68 | 31 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 5.13e-03 | 69 | 31 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 5.42e-03 | 71 | 31 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | transcription factor binding | 5.66e-03 | 753 | 31 | 5 | GO:0008134 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PAXIP1 MED15 SMARCA2 SMARCC1 KMT2C FOXP1 POU3F2 TSC22D1 KMT2D NFAT5 PRDM15 ATXN7 MAML3 MED12 NOTCH1 ARID3B | 1.90e-11 | 1390 | 31 | 16 | GO:0045944 |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 6.55e-06 | 3 | 31 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 8.91e-06 | 88 | 31 | 4 | GO:0006289 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | SMARCA2 SMARCC1 KMT2C FOXP1 POU3F2 TSC22D1 KMT2D FOXP2 NOTCH1 | 4.36e-05 | 1190 | 31 | 9 | GO:0008284 |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 4.57e-05 | 7 | 31 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | growth | 5.83e-05 | 1235 | 31 | 9 | GO:0040007 | |
| GeneOntologyBiologicalProcess | DNA damage response | 6.43e-05 | 959 | 31 | 8 | GO:0006974 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 8.57e-05 | 999 | 31 | 8 | GO:0071824 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 9.29e-05 | 741 | 31 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 1.48e-04 | 1081 | 31 | 8 | GO:0006259 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 1.57e-04 | 70 | 31 | 3 | GO:0060261 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.67e-04 | 564 | 31 | 6 | GO:0051052 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 2.09e-04 | 77 | 31 | 3 | GO:2000144 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 2.42e-04 | 81 | 31 | 3 | GO:0060260 | |
| GeneOntologyBiologicalProcess | neuroendocrine cell differentiation | 2.59e-04 | 16 | 31 | 2 | GO:0061101 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.00e-04 | 896 | 31 | 7 | GO:0006325 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell differentiation | 3.29e-04 | 18 | 31 | 2 | GO:0021702 | |
| GeneOntologyBiologicalProcess | developmental growth | 3.32e-04 | 911 | 31 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 3.41e-04 | 91 | 31 | 3 | GO:2000142 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 3.53e-04 | 92 | 31 | 3 | GO:0045661 | |
| GeneOntologyBiologicalProcess | DNA repair | 3.54e-04 | 648 | 31 | 6 | GO:0006281 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer formation | 4.08e-04 | 20 | 31 | 2 | GO:0021694 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 4.19e-04 | 237 | 31 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 4.53e-04 | 242 | 31 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | retinal cone cell differentiation | 4.96e-04 | 22 | 31 | 2 | GO:0042670 | |
| GeneOntologyBiologicalProcess | striatum development | 4.96e-04 | 22 | 31 | 2 | GO:0021756 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 5.91e-04 | 24 | 31 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 6.42e-04 | 25 | 31 | 2 | GO:0021692 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 7.30e-04 | 118 | 31 | 3 | GO:0001570 | |
| GeneOntologyBiologicalProcess | subpallium development | 8.06e-04 | 28 | 31 | 2 | GO:0021544 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 8.65e-04 | 29 | 31 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | smooth muscle tissue development | 8.65e-04 | 29 | 31 | 2 | GO:0048745 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 5.82e-07 | 12 | 30 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PAXIP1 MED15 SMARCA2 SMARCC1 KMT2C KMT2D ATXN7 AMOT MED12 SF3A1 RAD23B | 1.66e-06 | 1377 | 30 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.68e-04 | 75 | 30 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | npBAF complex | 1.79e-04 | 14 | 30 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 1.79e-04 | 14 | 30 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 1.79e-04 | 14 | 30 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 2.36e-04 | 16 | 30 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | methyltransferase complex | 4.92e-04 | 108 | 30 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | XY body | 4.94e-04 | 23 | 30 | 2 | GO:0001741 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 8.45e-04 | 30 | 30 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.05e-03 | 140 | 30 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | sex chromosome | 1.81e-03 | 44 | 30 | 2 | GO:0000803 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.86e-03 | 171 | 30 | 3 | GO:0034399 | |
| GeneOntologyCellularComponent | chromatin | 4.22e-03 | 1480 | 30 | 7 | GO:0000785 | |
| HumanPheno | Prominent fingertip pads | 5.46e-06 | 46 | 14 | 4 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 6.48e-06 | 48 | 14 | 4 | HP:0011298 | |
| HumanPheno | Expressive language delay | 1.21e-05 | 56 | 14 | 4 | HP:0002474 | |
| HumanPheno | Language delay | 1.21e-05 | 56 | 14 | 4 | HP:0002336 | |
| HumanPheno | Autistic behavior | 1.34e-05 | 678 | 14 | 9 | HP:0000729 | |
| HumanPheno | Diagnostic behavioral phenotype | 3.00e-05 | 747 | 14 | 9 | HP:0025783 | |
| HumanPheno | Recurrent maladaptive behavior | CIZ1 USP7 SMARCA2 TNRC6B KMT2C FOXP1 FOXP2 ATXN2 ATXN7 MED12 HCN1 | 4.52e-05 | 1293 | 14 | 11 | HP:5200241 |
| HumanPheno | Drooling | 4.71e-05 | 161 | 14 | 5 | HP:0002307 | |
| HumanPheno | Excessive salivation | 6.12e-05 | 170 | 14 | 5 | HP:0003781 | |
| HumanPheno | Supranuclear ophthalmoplegia | 6.98e-05 | 5 | 14 | 2 | HP:0000623 | |
| HumanPheno | Abnormal esophagus morphology | USP7 SMARCA2 KMT2C KMT2D FOXP2 ATXN2 ATXN7 MED12 HCN1 NOTCH1 | 7.49e-05 | 1078 | 14 | 10 | HP:0002031 |
| HumanPheno | Speech apraxia | 7.82e-05 | 32 | 14 | 3 | HP:0011098 | |
| HumanPheno | Enuresis | 9.41e-05 | 34 | 14 | 3 | HP:0000805 | |
| HumanPheno | Inguinal hernia | 9.94e-05 | 312 | 14 | 6 | HP:0000023 | |
| HumanPheno | Abnormally increased volition | 1.04e-04 | 869 | 14 | 9 | HP:5200263 | |
| HumanPheno | Impairment in personality functioning | 1.25e-04 | 1141 | 14 | 10 | HP:0031466 | |
| HumanPheno | Abnormal fingertip morphology | 1.43e-04 | 203 | 14 | 5 | HP:0001211 | |
| HumanPheno | Plagiocephaly | 1.60e-04 | 208 | 14 | 5 | HP:0001357 | |
| HumanPheno | Language impairment | USP7 SMARCA2 TNRC6B KMT2C FOXP1 KMT2D FOXP2 ATXN2 MED12 HCN1 | 1.67e-04 | 1178 | 14 | 10 | HP:0002463 |
| HumanPheno | Abnormal esophagus physiology | 1.85e-04 | 933 | 14 | 9 | HP:0025270 | |
| HumanPheno | Abnormality of salivation | 1.87e-04 | 215 | 14 | 5 | HP:0100755 | |
| HumanPheno | Gastroesophageal reflux | 1.94e-04 | 517 | 14 | 7 | HP:0002020 | |
| HumanPheno | Short attention span | 1.94e-04 | 517 | 14 | 7 | HP:0000736 | |
| HumanPheno | Reduced attention regulation | 2.16e-04 | 526 | 14 | 7 | HP:5200044 | |
| HumanPheno | Genetic anticipation | 2.50e-04 | 9 | 14 | 2 | HP:0003743 | |
| HumanPheno | Clinodactyly of the 2nd finger | 2.50e-04 | 9 | 14 | 2 | HP:0040022 | |
| HumanPheno | Abnormal motivation | USP7 SMARCA2 TNRC6B KMT2C FOXP1 FOXP2 ATXN2 ATXN7 MED12 HCN1 | 3.11e-04 | 1263 | 14 | 10 | HP:5200275 |
| HumanPheno | Abnormal volitional state | USP7 SMARCA2 TNRC6B KMT2C FOXP1 FOXP2 ATXN2 ATXN7 MED12 HCN1 | 3.11e-04 | 1263 | 14 | 10 | HP:0025780 |
| HumanPheno | Hyperactivity | 3.14e-04 | 558 | 14 | 7 | HP:0000752 | |
| HumanPheno | Functional abnormality of the gastrointestinal tract | USP7 SMARCA2 KMT2C KMT2D FOXP2 ATXN2 ATXN7 MED12 HCN1 NOTCH1 | 3.27e-04 | 1270 | 14 | 10 | HP:0012719 |
| HumanPheno | Partial anomalous pulmonary venous return | 3.80e-04 | 11 | 14 | 2 | HP:0010773 | |
| HumanPheno | Thick lower lip vermilion | 3.95e-04 | 136 | 14 | 4 | HP:0000179 | |
| HumanPheno | Reduced impulse control | 4.14e-04 | 1032 | 14 | 9 | HP:5200045 | |
| HumanPheno | Functional abnormality of the bladder | 4.45e-04 | 590 | 14 | 7 | HP:0000009 | |
| HumanPheno | Attention deficit hyperactivity disorder | 4.69e-04 | 413 | 14 | 6 | HP:0007018 | |
| HumanPheno | Disinhibition | 4.71e-04 | 807 | 14 | 8 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 4.71e-04 | 807 | 14 | 8 | HP:0000719 | |
| HumanPheno | Abnormal response to social norms | 4.71e-04 | 807 | 14 | 8 | HP:5200123 | |
| HumanPheno | Social disinhibition | 4.71e-04 | 807 | 14 | 8 | HP:5200029 | |
| HumanPheno | Anal atresia | 4.79e-04 | 143 | 14 | 4 | HP:0002023 | |
| HumanPheno | Coarctation of aorta | 5.74e-04 | 150 | 14 | 4 | HP:0001680 | |
| HumanPheno | Abnormality of the bladder | 6.13e-04 | 621 | 14 | 7 | HP:0000014 | |
| HumanPheno | Thick vermilion border | 6.32e-04 | 279 | 14 | 5 | HP:0012471 | |
| HumanPheno | Prominent lips | 6.66e-04 | 156 | 14 | 4 | HP:0000184 | |
| HumanPheno | Compulsive behaviors | 6.99e-04 | 158 | 14 | 4 | HP:0000722 | |
| HumanPheno | Receptive language delay | 7.22e-04 | 15 | 14 | 2 | HP:0010863 | |
| HumanPheno | Pulmonary arterial hypertension | 7.69e-04 | 162 | 14 | 4 | HP:0002092 | |
| HumanPheno | Pre-capillary pulmonary hypertension | 7.69e-04 | 162 | 14 | 4 | HP:0033578 | |
| HumanPheno | Elevated pulmonary artery pressure | 8.05e-04 | 164 | 14 | 4 | HP:0004890 | |
| HumanPheno | Delayed speech and language development | 8.06e-04 | 1123 | 14 | 9 | HP:0000750 | |
| HumanPheno | Failure to thrive | 8.34e-04 | 1128 | 14 | 9 | HP:0001508 | |
| HumanPheno | Abnormal size of the palpebral fissures | 8.56e-04 | 298 | 14 | 5 | HP:0200007 | |
| HumanPheno | Abnormality of the palpebral fissures | 8.65e-04 | 880 | 14 | 8 | HP:0008050 | |
| HumanPheno | Low frustration tolerance | 1.05e-03 | 18 | 14 | 2 | HP:0000744 | |
| HumanPheno | Dimple chin | 1.05e-03 | 18 | 14 | 2 | HP:0010751 | |
| HumanPheno | Abnormal social development | 1.08e-03 | 908 | 14 | 8 | HP:0025732 | |
| HumanPheno | Olivopontocerebellar atrophy | 1.17e-03 | 19 | 14 | 2 | HP:0002542 | |
| HumanPheno | Macrocephaly | 1.19e-03 | 491 | 14 | 6 | HP:0000256 | |
| HumanPheno | Downslanted palpebral fissures | 1.27e-03 | 497 | 14 | 6 | HP:0000494 | |
| HumanPheno | Abnormality of external features of the abdomen | 1.29e-03 | 326 | 14 | 5 | HP:0001462 | |
| HumanPheno | Deviation of the 2nd finger | 1.30e-03 | 20 | 14 | 2 | HP:0009468 | |
| HumanPheno | Hypersplenism | 1.30e-03 | 20 | 14 | 2 | HP:0001971 | |
| HumanPheno | Abnormal spleen physiology | 1.30e-03 | 20 | 14 | 2 | HP:0025409 | |
| HumanPheno | Increased head circumference | 1.31e-03 | 500 | 14 | 6 | HP:0040194 | |
| HumanPheno | Inheritance qualifier | 1.36e-03 | 330 | 14 | 5 | HP:0034335 | |
| HumanPheno | Early onset of sexual maturation | 1.37e-03 | 189 | 14 | 4 | HP:0100000 | |
| HumanPheno | Hernia of the abdominal wall | 1.40e-03 | 506 | 14 | 6 | HP:0004299 | |
| HumanPheno | Abnormal cerebral subcortex morphology | 1.41e-03 | 1207 | 14 | 9 | HP:0010993 | |
| HumanPheno | Abdominal wall defect | 1.47e-03 | 511 | 14 | 6 | HP:0010866 | |
| HumanPheno | Thoracoabdominal wall defect | 1.47e-03 | 511 | 14 | 6 | HP:0100656 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 1.53e-03 | 87 | 14 | 3 | HP:0000614 | |
| HumanPheno | Broad toe | 1.53e-03 | 87 | 14 | 3 | HP:0001837 | |
| HumanPheno | Aggressive behavior | 1.55e-03 | 516 | 14 | 6 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.55e-03 | 516 | 14 | 6 | HP:0006919 | |
| HumanPheno | Abnormally folded helix | 1.69e-03 | 90 | 14 | 3 | HP:0008544 | |
| HumanPheno | Narrow palate | 1.76e-03 | 202 | 14 | 4 | HP:0000189 | |
| HumanPheno | Abnormal stomach morphology | 1.82e-03 | 742 | 14 | 7 | HP:0002577 | |
| HumanPheno | Abnormal oral physiology | 1.89e-03 | 355 | 14 | 5 | HP:0031815 | |
| HumanPheno | Abnormality of pulmonary circulation | 1.96e-03 | 208 | 14 | 4 | HP:0030875 | |
| HumanPheno | Abnormality of the voice | 2.06e-03 | 545 | 14 | 6 | HP:0001608 | |
| HumanPheno | Skin tags | 2.09e-03 | 97 | 14 | 3 | HP:0010609 | |
| HumanPheno | Abnormal helix morphology | 2.10e-03 | 212 | 14 | 4 | HP:0011039 | |
| HumanPheno | Abnormal hallux morphology | 2.10e-03 | 212 | 14 | 4 | HP:0001844 | |
| HumanPheno | Abnormal semicircular canal morphology | 2.20e-03 | 26 | 14 | 2 | HP:0011380 | |
| HumanPheno | Single transverse palmar crease | 2.21e-03 | 215 | 14 | 4 | HP:0000954 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 2.22e-03 | 368 | 14 | 5 | HP:0031432 | |
| HumanPheno | Apraxia | 2.33e-03 | 218 | 14 | 4 | HP:0002186 | |
| HumanPheno | Aplasia/Hypoplasia of the ear | 2.37e-03 | 219 | 14 | 4 | HP:0008771 | |
| HumanPheno | Abnormality of the abdominal wall | 2.38e-03 | 560 | 14 | 6 | HP:0004298 | |
| HumanPheno | Perseverative thought | 2.47e-03 | 377 | 14 | 5 | HP:0030223 | |
| HumanPheno | Oromotor apraxia | 2.55e-03 | 28 | 14 | 2 | HP:0007301 | |
| HumanPheno | Mitral stenosis | 2.55e-03 | 28 | 14 | 2 | HP:0001718 | |
| HumanPheno | Abnormal anus morphology | 2.57e-03 | 224 | 14 | 4 | HP:0034915 | |
| HumanPheno | Recurrent otitis media | 2.70e-03 | 227 | 14 | 4 | HP:0000403 | |
| HumanPheno | Clinodactyly | 2.70e-03 | 574 | 14 | 6 | HP:0030084 | |
| HumanPheno | Disordered formal thought process | 2.75e-03 | 386 | 14 | 5 | HP:0025769 | |
| Domain | FOXP-CC | 1.49e-05 | 4 | 30 | 2 | PF16159 | |
| Domain | FOXP-CC | 1.49e-05 | 4 | 30 | 2 | IPR032354 | |
| Domain | FYrich_C | 2.49e-05 | 5 | 30 | 2 | IPR003889 | |
| Domain | FYrich_N | 2.49e-05 | 5 | 30 | 2 | IPR003888 | |
| Domain | FYRC | 2.49e-05 | 5 | 30 | 2 | SM00542 | |
| Domain | FYRN | 2.49e-05 | 5 | 30 | 2 | SM00541 | |
| Domain | FYRN | 2.49e-05 | 5 | 30 | 2 | PF05964 | |
| Domain | FYRC | 2.49e-05 | 5 | 30 | 2 | PF05965 | |
| Domain | FYRC | 2.49e-05 | 5 | 30 | 2 | PS51543 | |
| Domain | FYRN | 2.49e-05 | 5 | 30 | 2 | PS51542 | |
| Domain | SURP | 3.73e-05 | 6 | 30 | 2 | PS50128 | |
| Domain | Surp | 3.73e-05 | 6 | 30 | 2 | PF01805 | |
| Domain | SWAP | 3.73e-05 | 6 | 30 | 2 | SM00648 | |
| Domain | Surp | 3.73e-05 | 6 | 30 | 2 | IPR000061 | |
| Domain | SET | 5.42e-05 | 46 | 30 | 3 | SM00317 | |
| Domain | SET_dom | 6.97e-05 | 50 | 30 | 3 | IPR001214 | |
| Domain | SET | 6.97e-05 | 50 | 30 | 3 | PS50280 | |
| Domain | Post-SET_dom | 2.95e-04 | 16 | 30 | 2 | IPR003616 | |
| Domain | PostSET | 2.95e-04 | 16 | 30 | 2 | SM00508 | |
| Domain | RmlC_Cupin | 2.95e-04 | 16 | 30 | 2 | IPR011051 | |
| Domain | POST_SET | 2.95e-04 | 16 | 30 | 2 | PS50868 | |
| Domain | EPHD | 5.65e-04 | 22 | 30 | 2 | PS51805 | |
| Domain | BRCT_dom | 9.19e-04 | 28 | 30 | 2 | IPR001357 | |
| Domain | Znf_C2H2-like | 1.45e-03 | 796 | 30 | 6 | IPR015880 | |
| Domain | Znf_C2H2 | 1.54e-03 | 805 | 30 | 6 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.57e-03 | 808 | 30 | 6 | SM00355 | |
| Domain | SET | 1.97e-03 | 41 | 30 | 2 | PF00856 | |
| Domain | UBQ | 2.16e-03 | 43 | 30 | 2 | SM00213 | |
| Domain | TF_fork_head_CS_2 | 2.47e-03 | 46 | 30 | 2 | IPR030456 | |
| Domain | ubiquitin | 2.58e-03 | 47 | 30 | 2 | PF00240 | |
| Domain | TF_fork_head_CS_1 | 2.58e-03 | 47 | 30 | 2 | IPR018122 | |
| Domain | FORK_HEAD_3 | 2.80e-03 | 49 | 30 | 2 | PS50039 | |
| Domain | FH | 2.80e-03 | 49 | 30 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.80e-03 | 49 | 30 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.80e-03 | 49 | 30 | 2 | PS00658 | |
| Domain | Forkhead | 2.80e-03 | 49 | 30 | 2 | PF00250 | |
| Domain | Fork_head_dom | 2.80e-03 | 49 | 30 | 2 | IPR001766 | |
| Domain | HMG_box | 3.27e-03 | 53 | 30 | 2 | PF00505 | |
| Domain | HMG | 3.39e-03 | 54 | 30 | 2 | SM00398 | |
| Domain | UBIQUITIN_2 | 3.39e-03 | 54 | 30 | 2 | PS50053 | |
| Domain | Ubiquitin_dom | 3.90e-03 | 58 | 30 | 2 | IPR000626 | |
| Domain | UBA-like | 4.73e-03 | 64 | 30 | 2 | IPR009060 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.94e-07 | 65 | 29 | 5 | M39682 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.31e-07 | 29 | 29 | 4 | M48076 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | PAXIP1 MED15 SMARCA2 SMARCC1 TNRC6B KMT2C FOXP1 POU3F2 TSC22D1 KMT2D MAML3 MED12 NOTCH1 | 1.66e-06 | 1432 | 29 | 13 | M509 |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.97e-06 | 301 | 29 | 7 | MM15983 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 4.04e-05 | 95 | 29 | 4 | M48268 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 8.51e-05 | 42 | 29 | 3 | M48018 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.10e-04 | 237 | 29 | 5 | M27786 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.52e-04 | 254 | 29 | 5 | M27131 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.68e-04 | 137 | 29 | 4 | M48232 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.82e-04 | 10 | 29 | 2 | MM15535 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.09e-04 | 272 | 29 | 5 | M29619 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.66e-04 | 12 | 29 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.66e-04 | 12 | 29 | 2 | M47533 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED15 USP7 SMARCA2 SMARCC1 TNRC6B KMT2C KMT2D MAML3 MED12 NOTCH1 | 2.86e-04 | 1387 | 29 | 10 | M734 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 3.14e-04 | 13 | 29 | 2 | M47534 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.66e-04 | 14 | 29 | 2 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 4.82e-04 | 16 | 29 | 2 | M27121 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 4.97e-04 | 76 | 29 | 3 | M40057 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.13e-04 | 18 | 29 | 2 | MM14775 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 6.84e-04 | 19 | 29 | 2 | M48238 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.59e-04 | 20 | 29 | 2 | M27881 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 9.84e-04 | 96 | 29 | 3 | M27792 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.01e-03 | 23 | 29 | 2 | MM14954 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.19e-03 | 25 | 29 | 2 | M27880 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.39e-03 | 27 | 29 | 2 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.49e-03 | 28 | 29 | 2 | M6177 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.83e-03 | 119 | 29 | 3 | M607 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 1.83e-03 | 31 | 29 | 2 | M27393 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.95e-03 | 32 | 29 | 2 | M48012 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.96e-03 | 122 | 29 | 3 | M29689 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.33e-03 | 35 | 29 | 2 | M47969 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.60e-03 | 37 | 29 | 2 | M27797 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.74e-03 | 38 | 29 | 2 | MM17073 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.89e-03 | 39 | 29 | 2 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.34e-03 | 42 | 29 | 2 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 3.34e-03 | 42 | 29 | 2 | M17541 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 3.83e-03 | 45 | 29 | 2 | M39571 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 3.91e-03 | 1022 | 29 | 7 | MM15436 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 4.00e-03 | 46 | 29 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.17e-03 | 47 | 29 | 2 | M7946 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.35e-03 | 48 | 29 | 2 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.53e-03 | 49 | 29 | 2 | M618 | |
| Pathway | PID_AR_TF_PATHWAY | 5.28e-03 | 53 | 29 | 2 | M151 | |
| Pubmed | 5.23e-17 | 23 | 31 | 7 | 9225980 | ||
| Pubmed | PAXIP1 MED15 USP7 SMARCA2 SMARCC1 FOXP1 KMT2D CHERP MED12 ARID3B | 2.40e-14 | 268 | 31 | 10 | 33640491 | |
| Pubmed | PAXIP1 MED15 USP7 SMARCA2 SMARCC1 TNRC6B KMT2C FOXP1 R3HDM2 KMT2D FOXP2 ATXN2 ATXN7 PRRC2C ARID3B | 2.42e-13 | 1429 | 31 | 15 | 35140242 | |
| Pubmed | CIZ1 MED15 USP7 SMARCC1 TNRC6B KMT2C KMT2D AMOT PRRC2C MED12 ARID3B | 8.74e-13 | 549 | 31 | 11 | 38280479 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | PAXIP1 CIZ1 MED15 USP7 SMARCA2 SMARCC1 KMT2C FOXP1 KMT2D ARID3B | 1.23e-12 | 398 | 31 | 10 | 35016035 |
| Pubmed | PAXIP1 MED15 SMARCA2 SMARCC1 KMT2C FOXP1 KMT2D ATXN2 PRRC2C MED12 SF3A1 ARID3B RAD23B | 3.72e-12 | 1103 | 31 | 13 | 34189442 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.63e-11 | 351 | 31 | 9 | 38297188 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.68e-10 | 457 | 31 | 9 | 32344865 | |
| Pubmed | 1.75e-09 | 399 | 31 | 8 | 35987950 | ||
| Pubmed | 3.19e-09 | 65 | 31 | 5 | 26655900 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 26744420 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 7.47e-09 | 167 | 31 | 6 | 20362541 | |
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 1.04e-08 | 28 | 31 | 4 | 23643363 | |
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 8896557 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.86e-08 | 220 | 31 | 6 | 35785414 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 3.98e-08 | 857 | 31 | 9 | 25609649 | |
| Pubmed | 4.61e-08 | 608 | 31 | 8 | 16713569 | ||
| Pubmed | 6.67e-08 | 638 | 31 | 8 | 31182584 | ||
| Pubmed | 7.26e-08 | 645 | 31 | 8 | 25281560 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 1.82e-07 | 13 | 31 | 3 | 17761849 | |
| Pubmed | 2.31e-07 | 152 | 31 | 5 | 38360978 | ||
| Pubmed | 2.90e-07 | 15 | 31 | 3 | 17925232 | ||
| Pubmed | 3.56e-07 | 16 | 31 | 3 | 24368734 | ||
| Pubmed | 3.58e-07 | 66 | 31 | 4 | 23275444 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SMARCA2 TNRC6B KMT2C FOXP1 TSC22D1 NFAT5 ATXN2 PRDM15 ATXN7 MAML3 | 3.90e-07 | 1489 | 31 | 10 | 28611215 |
| Pubmed | 4.03e-07 | 808 | 31 | 8 | 20412781 | ||
| Pubmed | CIZ1 MED15 USP7 SMARCA2 TNRC6B KMT2C ATXN2 ATXN7 MED12 RAD23B | 4.10e-07 | 1497 | 31 | 10 | 31527615 | |
| Pubmed | 4.32e-07 | 17 | 31 | 3 | 26180087 | ||
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 5.18e-07 | 18 | 31 | 3 | 17500065 | |
| Pubmed | 5.81e-07 | 183 | 31 | 5 | 36129980 | ||
| Pubmed | 7.03e-07 | 78 | 31 | 4 | 28611094 | ||
| Pubmed | 7.23e-07 | 20 | 31 | 3 | 34220450 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 7.23e-07 | 20 | 31 | 3 | 29785026 | |
| Pubmed | 7.23e-07 | 20 | 31 | 3 | 19047629 | ||
| Pubmed | 7.23e-07 | 20 | 31 | 3 | 33431871 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 28483418 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 30031127 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 7.69e-07 | 2 | 31 | 2 | 30104377 | |
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 7.69e-07 | 2 | 31 | 2 | 34156443 | |
| Pubmed | USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia. | 7.69e-07 | 2 | 31 | 2 | 30370059 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 31924266 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 27280393 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 11504912 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 8595911 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 36869380 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 28967912 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 24893771 | ||
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 7.69e-07 | 2 | 31 | 2 | 15056695 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 25853299 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 27224915 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 25346535 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 11358962 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 28741757 | ||
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 7.69e-07 | 2 | 31 | 2 | 38761373 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 36601880 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 26647308 | ||
| Pubmed | 9.03e-07 | 83 | 31 | 4 | 28794006 | ||
| Pubmed | 9.40e-07 | 1247 | 31 | 9 | 27684187 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 9.76e-07 | 22 | 31 | 3 | 26886794 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.28e-06 | 1294 | 31 | 9 | 30804502 | |
| Pubmed | Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors. | 1.28e-06 | 24 | 31 | 3 | 22522401 | |
| Pubmed | 1.42e-06 | 653 | 31 | 7 | 22586326 | ||
| Pubmed | Zbtb20 modulates the sequential generation of neuronal layers in developing cortex. | 1.46e-06 | 25 | 31 | 3 | 27282384 | |
| Pubmed | ATR maintains select progenitors during nervous system development. | 1.46e-06 | 25 | 31 | 3 | 22266795 | |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 1.69e-06 | 97 | 31 | 4 | 37151849 | |
| Pubmed | 1.83e-06 | 99 | 31 | 4 | 34161765 | ||
| Pubmed | 2.07e-06 | 28 | 31 | 3 | 29365100 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 14516685 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 10713882 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 27566587 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 2.31e-06 | 3 | 31 | 2 | 19907493 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 23932714 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 28507505 | ||
| Pubmed | Cloning of novel trinucleotide-repeat (CAG) containing genes in mouse brain. | 2.31e-06 | 3 | 31 | 2 | 9367917 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 34958806 | ||
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 2.31e-06 | 3 | 31 | 2 | 22183980 | |
| Pubmed | Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. | 2.31e-06 | 3 | 31 | 2 | 12687690 | |
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 2.31e-06 | 3 | 31 | 2 | 25027557 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 35411950 | ||
| Pubmed | Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization. | 2.31e-06 | 3 | 31 | 2 | 28204507 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 21683083 | ||
| Pubmed | 2.74e-06 | 251 | 31 | 5 | 31076518 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 2.83e-06 | 31 | 31 | 3 | 20516061 | |
| Pubmed | 3.22e-06 | 469 | 31 | 6 | 27634302 | ||
| Pubmed | 3.82e-06 | 119 | 31 | 4 | 23508102 | ||
| Pubmed | 4.48e-06 | 1116 | 31 | 8 | 31753913 | ||
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 4.61e-06 | 4 | 31 | 2 | 19221051 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 34645806 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 14701752 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 28398509 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 4.61e-06 | 4 | 31 | 2 | 23129768 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 19703992 | ||
| Pubmed | HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis. | 4.61e-06 | 4 | 31 | 2 | 30270123 | |
| Pubmed | Extrinsic Regulators of mRNA Translation in Developing Brain: Story of WNTs. | 4.61e-06 | 4 | 31 | 2 | 33525513 | |
| Pubmed | Identification and characterization of T reg-like cells in zebrafish. | 4.61e-06 | 4 | 31 | 2 | 29066577 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 24081332 | ||
| Pubmed | Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. | 4.61e-06 | 4 | 31 | 2 | 9744861 | |
| Pubmed | Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. | 4.61e-06 | 4 | 31 | 2 | 24421395 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 16452305 | ||
| Pubmed | 5.26e-06 | 129 | 31 | 4 | 23022380 | ||
| Interaction | SOX9 interactions | 1.15e-12 | 97 | 30 | 8 | int:SOX9 | |
| Interaction | CRX interactions | PAXIP1 MED15 SMARCA2 SMARCC1 KMT2C FOXP1 KMT2D FOXP2 ATXN7 MED12 | 2.04e-12 | 254 | 30 | 10 | int:CRX |
| Interaction | YAP1 interactions | CIZ1 MED15 USP7 SMARCA2 SMARCC1 TNRC6B KMT2C POU3F2 KMT2D NFAT5 AMOT PRRC2C MED12 SF3A1 ARID3B | 6.94e-12 | 1095 | 30 | 15 | int:YAP1 |
| Interaction | SOX7 interactions | 2.68e-11 | 82 | 30 | 7 | int:SOX7 | |
| Interaction | GATA2 interactions | 3.81e-10 | 199 | 30 | 8 | int:GATA2 | |
| Interaction | GCM1 interactions | 6.56e-10 | 68 | 30 | 6 | int:GCM1 | |
| Interaction | EGR2 interactions | 4.84e-09 | 171 | 30 | 7 | int:EGR2 | |
| Interaction | HNF4A interactions | 4.90e-09 | 275 | 30 | 8 | int:HNF4A | |
| Interaction | TLX1 interactions | 5.68e-09 | 175 | 30 | 7 | int:TLX1 | |
| Interaction | NUP35 interactions | 7.18e-09 | 424 | 30 | 9 | int:NUP35 | |
| Interaction | AR interactions | PAXIP1 MED15 USP7 SMARCA2 SMARCC1 KMT2C FOXP1 KMT2D CHERP TNS1 MED12 ARID3B | 7.19e-09 | 992 | 30 | 12 | int:AR |
| Interaction | LHX2 interactions | 7.74e-09 | 183 | 30 | 7 | int:LHX2 | |
| Interaction | CEBPA interactions | PAXIP1 MED15 SMARCA2 SMARCC1 KMT2C FOXP1 KMT2D ATXN2 PRRC2C MED12 SF3A1 ARID3B RAD23B | 7.99e-09 | 1245 | 30 | 13 | int:CEBPA |
| Interaction | HNF1B interactions | 1.00e-08 | 190 | 30 | 7 | int:HNF1B | |
| Interaction | TBXT interactions | 1.69e-08 | 116 | 30 | 6 | int:TBXT | |
| Interaction | NFIX interactions | 3.42e-08 | 227 | 30 | 7 | int:NFIX | |
| Interaction | NFIB interactions | 5.68e-08 | 142 | 30 | 6 | int:NFIB | |
| Interaction | WWTR1 interactions | 1.35e-07 | 422 | 30 | 8 | int:WWTR1 | |
| Interaction | PAX2 interactions | 1.55e-07 | 85 | 30 | 5 | int:PAX2 | |
| Interaction | IRF4 interactions | 1.55e-07 | 85 | 30 | 5 | int:IRF4 | |
| Interaction | GSC interactions | 1.75e-07 | 87 | 30 | 5 | int:GSC | |
| Interaction | TEAD1 interactions | 2.03e-07 | 176 | 30 | 6 | int:TEAD1 | |
| Interaction | FOXI1 interactions | 2.31e-07 | 92 | 30 | 5 | int:FOXI1 | |
| Interaction | SP7 interactions | 2.51e-07 | 304 | 30 | 7 | int:SP7 | |
| Interaction | SOX17 interactions | 2.72e-07 | 95 | 30 | 5 | int:SOX17 | |
| Interaction | GATA3 interactions | 2.91e-07 | 187 | 30 | 6 | int:GATA3 | |
| Interaction | FOS interactions | 2.99e-07 | 312 | 30 | 7 | int:FOS | |
| Interaction | NFIA interactions | 3.00e-07 | 188 | 30 | 6 | int:NFIA | |
| Interaction | BMI1 interactions | 3.13e-07 | 659 | 30 | 9 | int:BMI1 | |
| Interaction | MYOD1 interactions | 3.61e-07 | 194 | 30 | 6 | int:MYOD1 | |
| Interaction | NANOG interactions | 3.66e-07 | 481 | 30 | 8 | int:NANOG | |
| Interaction | KLF5 interactions | 3.72e-07 | 195 | 30 | 6 | int:KLF5 | |
| Interaction | FOXL1 interactions | 3.83e-07 | 196 | 30 | 6 | int:FOXL1 | |
| Interaction | PAX8 interactions | 5.91e-07 | 111 | 30 | 5 | int:PAX8 | |
| Interaction | TBR1 interactions | 6.46e-07 | 113 | 30 | 5 | int:TBR1 | |
| Interaction | ERG interactions | 8.16e-07 | 223 | 30 | 6 | int:ERG | |
| Interaction | PAX6 interactions | 8.74e-07 | 366 | 30 | 7 | int:PAX6 | |
| Interaction | PAX7 interactions | 1.02e-06 | 124 | 30 | 5 | int:PAX7 | |
| Interaction | CCDC97 interactions | 1.20e-06 | 54 | 30 | 4 | int:CCDC97 | |
| Interaction | PAX9 interactions | 1.29e-06 | 130 | 30 | 5 | int:PAX9 | |
| Interaction | EYA4 interactions | 1.35e-06 | 243 | 30 | 6 | int:EYA4 | |
| Interaction | RBPJ interactions | 1.74e-06 | 254 | 30 | 6 | int:RBPJ | |
| Interaction | SREBF1 interactions | 2.62e-06 | 150 | 30 | 5 | int:SREBF1 | |
| Interaction | FOXP3 interactions | 2.63e-06 | 432 | 30 | 7 | int:FOXP3 | |
| Interaction | CPEB4 interactions | 3.18e-06 | 156 | 30 | 5 | int:CPEB4 | |
| Interaction | KLF4 interactions | 3.60e-06 | 160 | 30 | 5 | int:KLF4 | |
| Interaction | CELF1 interactions | 3.60e-06 | 288 | 30 | 6 | int:CELF1 | |
| Interaction | TLX3 interactions | 3.82e-06 | 291 | 30 | 6 | int:TLX3 | |
| Interaction | HCFC1 interactions | 3.97e-06 | 293 | 30 | 6 | int:HCFC1 | |
| Interaction | GATA1 interactions | 4.98e-06 | 171 | 30 | 5 | int:GATA1 | |
| Interaction | UTY interactions | 5.17e-06 | 23 | 30 | 3 | int:UTY | |
| Interaction | PPARG interactions | 5.19e-06 | 307 | 30 | 6 | int:PPARG | |
| Interaction | KMT2A interactions | 5.91e-06 | 314 | 30 | 6 | int:KMT2A | |
| Interaction | KDM1A interactions | 5.98e-06 | 941 | 30 | 9 | int:KDM1A | |
| Interaction | SMG7 interactions | 6.47e-06 | 319 | 30 | 6 | int:SMG7 | |
| Interaction | ALG13 interactions | 6.93e-06 | 183 | 30 | 5 | int:ALG13 | |
| Interaction | LHX3 interactions | 7.30e-06 | 185 | 30 | 5 | int:LHX3 | |
| Interaction | NR3C1 interactions | 7.91e-06 | 974 | 30 | 9 | int:NR3C1 | |
| Interaction | MAFA interactions | 8.50e-06 | 27 | 30 | 3 | int:MAFA | |
| Interaction | FAM120C interactions | 8.53e-06 | 191 | 30 | 5 | int:FAM120C | |
| Interaction | PHIP interactions | 9.91e-06 | 197 | 30 | 5 | int:PHIP | |
| Interaction | SOX10 interactions | 1.02e-05 | 92 | 30 | 4 | int:SOX10 | |
| Interaction | FEV interactions | 1.15e-05 | 203 | 30 | 5 | int:FEV | |
| Interaction | NFIC interactions | 1.35e-05 | 210 | 30 | 5 | int:NFIC | |
| Interaction | CDK8 interactions | 1.77e-05 | 222 | 30 | 5 | int:CDK8 | |
| Interaction | MEX3B interactions | 1.77e-05 | 222 | 30 | 5 | int:MEX3B | |
| Interaction | SMAD2 interactions | 1.88e-05 | 385 | 30 | 6 | int:SMAD2 | |
| Interaction | MKRN2 interactions | 1.88e-05 | 385 | 30 | 6 | int:MKRN2 | |
| Interaction | EN1 interactions | 2.06e-05 | 110 | 30 | 4 | int:EN1 | |
| Interaction | EP300 interactions | PAXIP1 USP7 SMARCA2 SMARCC1 POU3F2 KMT2D ATXN7 AMOT SF3A1 NOTCH1 | 2.12e-05 | 1401 | 30 | 10 | int:EP300 |
| Interaction | HDAC1 interactions | 2.22e-05 | 1108 | 30 | 9 | int:HDAC1 | |
| Interaction | WWP2 interactions | 2.28e-05 | 840 | 30 | 8 | int:WWP2 | |
| Interaction | OTUD4 interactions | 2.37e-05 | 236 | 30 | 5 | int:OTUD4 | |
| Interaction | SOX2 interactions | PAXIP1 USP7 SMARCA2 SMARCC1 KMT2C FOXP1 APOA4 KMT2D ARID3B RAD23B | 2.41e-05 | 1422 | 30 | 10 | int:SOX2 |
| Interaction | NFAT5 interactions | 2.42e-05 | 38 | 30 | 3 | int:NFAT5 | |
| Interaction | MDC1 interactions | 2.83e-05 | 414 | 30 | 6 | int:MDC1 | |
| Interaction | ETS1 interactions | 3.00e-05 | 121 | 30 | 4 | int:ETS1 | |
| Interaction | HELZ interactions | 3.56e-05 | 257 | 30 | 5 | int:HELZ | |
| Interaction | SRCAP interactions | 3.63e-05 | 127 | 30 | 4 | int:SRCAP | |
| Interaction | MARF1 interactions | 3.74e-05 | 128 | 30 | 4 | int:MARF1 | |
| Interaction | H3C1 interactions | 3.76e-05 | 901 | 30 | 8 | int:H3C1 | |
| Interaction | TAF1 interactions | 3.76e-05 | 260 | 30 | 5 | int:TAF1 | |
| Interaction | R3HDM2 interactions | 3.86e-05 | 129 | 30 | 4 | int:R3HDM2 | |
| Interaction | ESRRB interactions | 3.90e-05 | 262 | 30 | 5 | int:ESRRB | |
| Interaction | KMT2B interactions | 3.98e-05 | 130 | 30 | 4 | int:KMT2B | |
| Interaction | MED23 interactions | 4.20e-05 | 266 | 30 | 5 | int:MED23 | |
| Interaction | TOP2B interactions | 4.20e-05 | 266 | 30 | 5 | int:TOP2B | |
| Interaction | CXXC1 interactions | 4.22e-05 | 132 | 30 | 4 | int:CXXC1 | |
| Interaction | BRCC3 interactions | 4.22e-05 | 132 | 30 | 4 | int:BRCC3 | |
| Interaction | MYB interactions | 4.35e-05 | 133 | 30 | 4 | int:MYB | |
| Interaction | KMT2C interactions | 4.48e-05 | 134 | 30 | 4 | int:KMT2C | |
| Interaction | HLTF interactions | 5.17e-05 | 139 | 30 | 4 | int:HLTF | |
| Interaction | SRRM2 interactions | 5.23e-05 | 462 | 30 | 6 | int:SRRM2 | |
| Interaction | TNRC6A interactions | 5.36e-05 | 280 | 30 | 5 | int:TNRC6A | |
| Interaction | TLX2 interactions | 5.62e-05 | 142 | 30 | 4 | int:TLX2 | |
| Interaction | PAGR1 interactions | 5.91e-05 | 51 | 30 | 3 | int:PAGR1 | |
| Interaction | PABPC1 interactions | 5.94e-05 | 699 | 30 | 7 | int:PABPC1 | |
| Interaction | RBBP5 interactions | 6.02e-05 | 287 | 30 | 5 | int:RBBP5 | |
| Interaction | NCOA6 interactions | 6.09e-05 | 145 | 30 | 4 | int:NCOA6 | |
| Interaction | DAZL interactions | 6.09e-05 | 145 | 30 | 4 | int:DAZL | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.78e-18 | 25 | 24 | 8 | 775 | |
| GeneFamily | Ataxins|MJD deubiquinating enzymes | 2.52e-05 | 6 | 24 | 2 | 411 | |
| GeneFamily | Cyclins|Mediator complex | 8.70e-04 | 33 | 24 | 2 | 1061 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.23e-04 | 34 | 24 | 2 | 487 | |
| GeneFamily | Forkhead boxes | 1.48e-03 | 43 | 24 | 2 | 508 | |
| GeneFamily | PHD finger proteins | 6.30e-03 | 90 | 24 | 2 | 88 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 3.16e-05 | 1102 | 31 | 8 | M2369 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 3.64e-05 | 1124 | 31 | 8 | MM1070 | |
| Coexpression | GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN | 4.69e-05 | 170 | 31 | 4 | M6855 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.85e-05 | 180 | 31 | 4 | M8239 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 7.83e-05 | 194 | 31 | 4 | M3321 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 8.64e-05 | 199 | 31 | 4 | M9443 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 8.64e-05 | 199 | 31 | 4 | M6964 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 8.64e-05 | 199 | 31 | 4 | M6987 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 8.81e-05 | 200 | 31 | 4 | M9463 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 8.81e-05 | 200 | 31 | 4 | M304 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 8.81e-05 | 200 | 31 | 4 | M9273 | |
| Coexpression | KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP | 8.81e-05 | 200 | 31 | 4 | M3012 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 9.15e-05 | 202 | 31 | 4 | M11840 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 9.21e-05 | 394 | 31 | 5 | MM3724 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 1.06e-04 | 210 | 31 | 4 | M1303 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 1.12e-04 | 213 | 31 | 4 | MM1125 | |
| Coexpression | ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON | 1.34e-04 | 84 | 31 | 3 | M39095 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.02e-04 | 466 | 31 | 5 | M13522 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.04e-04 | 467 | 31 | 5 | M1347 | |
| Coexpression | PYEON_HPV_POSITIVE_TUMORS_UP | 2.31e-04 | 101 | 31 | 3 | M7738 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.40e-04 | 484 | 31 | 5 | MM999 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 2.52e-04 | 104 | 31 | 3 | M1318 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 2.63e-04 | 1492 | 31 | 8 | M40023 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 2.74e-04 | 107 | 31 | 3 | MM1130 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.36e-04 | 856 | 31 | 6 | M4500 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 6.13e-04 | 141 | 31 | 3 | M7720 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 6.13e-04 | 141 | 31 | 3 | M39235 | |
| Coexpression | PDGF_ERK_DN.V1_UP | 6.65e-04 | 145 | 31 | 3 | M2830 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 6.99e-04 | 33 | 31 | 2 | M1359 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | 7.23e-04 | 942 | 31 | 6 | M8144 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 8.32e-04 | 36 | 31 | 2 | M4389 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 8.32e-04 | 36 | 31 | 2 | MM513 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 8.38e-04 | 157 | 31 | 3 | M7733 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 8.79e-04 | 37 | 31 | 2 | MM570 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 9.27e-04 | 38 | 31 | 2 | M39244 | |
| Coexpression | GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP | 9.84e-04 | 166 | 31 | 3 | M7730 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 9.84e-04 | 166 | 31 | 3 | M7722 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.02e-03 | 168 | 31 | 3 | M1124 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 1.03e-03 | 1399 | 31 | 7 | M535 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.04e-03 | 169 | 31 | 3 | M39230 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | 1.05e-03 | 385 | 31 | 4 | M2840 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.18e-03 | 177 | 31 | 3 | M39245 | |
| Coexpression | BENPORATH_NOS_TARGETS | 1.22e-03 | 179 | 31 | 3 | M14573 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.28e-03 | 182 | 31 | 3 | MM993 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_DN | 1.30e-03 | 45 | 31 | 2 | MM634 | |
| Coexpression | MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP | 1.30e-03 | 45 | 31 | 2 | M45041 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_DN | 1.36e-03 | 46 | 31 | 2 | M1455 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.41e-03 | 417 | 31 | 4 | M39224 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.43e-03 | 189 | 31 | 3 | M3112 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 1.43e-03 | 189 | 31 | 3 | M8275 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP | 1.52e-03 | 193 | 31 | 3 | M6130 | |
| Coexpression | GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN | 1.52e-03 | 193 | 31 | 3 | M6138 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP | 1.54e-03 | 194 | 31 | 3 | M4192 | |
| Coexpression | GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP | 1.56e-03 | 195 | 31 | 3 | M3319 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP | 1.56e-03 | 195 | 31 | 3 | M3400 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 1.56e-03 | 195 | 31 | 3 | M7397 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 1.58e-03 | 734 | 31 | 5 | M3835 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 1.59e-03 | 196 | 31 | 3 | M4928 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP | 1.59e-03 | 196 | 31 | 3 | M7588 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 1.59e-03 | 196 | 31 | 3 | M5381 | |
| Coexpression | OSMAN_BLADDER_CANCER_DN | 1.60e-03 | 431 | 31 | 4 | M16858 | |
| Coexpression | CHUNG_BLISTER_CYTOTOXICITY_DN | 1.60e-03 | 50 | 31 | 2 | M10850 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP | 1.61e-03 | 197 | 31 | 3 | M3133 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 1.61e-03 | 197 | 31 | 3 | M4421 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.61e-03 | 432 | 31 | 4 | M41149 | |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN | 1.63e-03 | 198 | 31 | 3 | M8169 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.63e-03 | 198 | 31 | 3 | M8624 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN | 1.63e-03 | 198 | 31 | 3 | M9234 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 1.63e-03 | 198 | 31 | 3 | M6123 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 1.63e-03 | 198 | 31 | 3 | M4415 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.63e-03 | 198 | 31 | 3 | M7948 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.66e-03 | 199 | 31 | 3 | M9498 | |
| Coexpression | GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP | 1.66e-03 | 199 | 31 | 3 | M8580 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 1.66e-03 | 199 | 31 | 3 | M8974 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 1.66e-03 | 199 | 31 | 3 | M9269 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN | 1.66e-03 | 199 | 31 | 3 | M5707 | |
| Coexpression | KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN | 1.66e-03 | 199 | 31 | 3 | M3028 | |
| Coexpression | BURTON_ADIPOGENESIS_11 | 1.66e-03 | 51 | 31 | 2 | MM1197 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 1.68e-03 | 200 | 31 | 3 | M5063 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 1.68e-03 | 200 | 31 | 3 | M5055 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 1.68e-03 | 200 | 31 | 3 | M9449 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.68e-03 | 200 | 31 | 3 | M291 | |
| Coexpression | GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN | 1.68e-03 | 200 | 31 | 3 | M5101 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP | 1.68e-03 | 200 | 31 | 3 | M7764 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 1.68e-03 | 200 | 31 | 3 | M6447 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP | 1.68e-03 | 200 | 31 | 3 | M6832 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 1.68e-03 | 200 | 31 | 3 | M5995 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | 1.68e-03 | 200 | 31 | 3 | M8427 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 1.68e-03 | 200 | 31 | 3 | M9341 | |
| Coexpression | GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 1.68e-03 | 200 | 31 | 3 | M9843 | |
| Coexpression | GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP | 1.68e-03 | 200 | 31 | 3 | M5842 | |
| Coexpression | GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN | 1.68e-03 | 200 | 31 | 3 | M3659 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 1.68e-03 | 200 | 31 | 3 | M331 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | 1.68e-03 | 200 | 31 | 3 | M9262 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 1.68e-03 | 200 | 31 | 3 | M9258 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 1.68e-03 | 200 | 31 | 3 | M3510 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN | 1.68e-03 | 200 | 31 | 3 | M6687 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | 1.68e-03 | 200 | 31 | 3 | M8278 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 1.68e-03 | 200 | 31 | 3 | M9133 | |
| Coexpression | GSE360_DC_VS_MAC_UP | 1.68e-03 | 200 | 31 | 3 | M5172 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.26e-06 | 790 | 31 | 9 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.41e-06 | 801 | 31 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.42e-05 | 799 | 31 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.55e-05 | 413 | 31 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.02e-05 | 281 | 31 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.28e-05 | 284 | 31 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 8.75e-05 | 162 | 31 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 1.73e-04 | 843 | 31 | 7 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.74e-04 | 844 | 31 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.20e-04 | 385 | 31 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.81e-04 | 406 | 31 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.35e-04 | 230 | 31 | 4 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | alpha beta T cells, preT.ETP-2A.Th, Lin-/lo CD25int CD44+ cKit+, Thymus, avg-2 | 3.51e-04 | 426 | 31 | 5 | GSM791152_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.53e-04 | 249 | 31 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.25e-04 | 259 | 31 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.58e-04 | 275 | 31 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.76e-04 | 277 | 31 | 4 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 8.92e-04 | 795 | 31 | 6 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 9.04e-04 | 797 | 31 | 6 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 9.46e-04 | 804 | 31 | 6 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 9.58e-04 | 806 | 31 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 9.60e-04 | 532 | 31 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 1.03e-03 | 818 | 31 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.72e-06 | 162 | 31 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.98e-06 | 185 | 31 | 4 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.15e-06 | 186 | 31 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.15e-06 | 186 | 31 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.43e-06 | 193 | 31 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.43e-06 | 193 | 31 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 199 | 31 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 152 | 31 | 3 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 152 | 31 | 3 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 156 | 31 | 3 | ba9dfee9373d657d2a55572b41fc62001ad8b037 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.95e-04 | 163 | 31 | 3 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.95e-04 | 163 | 31 | 3 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 164 | 31 | 3 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.05e-04 | 166 | 31 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 176 | 31 | 3 | 0f056597bc9e53176ce8670924ac925c801964b5 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 176 | 31 | 3 | d04be5acf0be46adc3d2055f6f21358c02792817 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-04 | 178 | 31 | 3 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.56e-04 | 179 | 31 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-04 | 180 | 31 | 3 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-04 | 182 | 31 | 3 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-04 | 182 | 31 | 3 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.78e-04 | 184 | 31 | 3 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 185 | 31 | 3 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-04 | 186 | 31 | 3 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-04 | 186 | 31 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-04 | 187 | 31 | 3 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.96e-04 | 188 | 31 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.96e-04 | 188 | 31 | 3 | 263169029293e005bcffd87db20221fdd2d3917e | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.96e-04 | 188 | 31 | 3 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-04 | 190 | 31 | 3 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.10e-04 | 191 | 31 | 3 | b680e0c35f1004be36f9f0680ae3c62952e2b607 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.15e-04 | 192 | 31 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.15e-04 | 192 | 31 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | 1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486 | |
| ToppCell | PND10-Endothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | f3c743b340fc588bc8effd375b12e2c7cbfa49d2 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 3.20e-04 | 193 | 31 | 3 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-04 | 194 | 31 | 3 | 1b382508453c5b08fb617f626b230adf3b6cff99 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-04 | 195 | 31 | 3 | cd011433b3b9bfb1adb13eca2f3f2a5db024cd94 | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.30e-04 | 195 | 31 | 3 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-04 | 195 | 31 | 3 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.30e-04 | 195 | 31 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 196 | 31 | 3 | fd0a2b863dedaf08d18e7f67da18ac7e853991e4 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 196 | 31 | 3 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 196 | 31 | 3 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 196 | 31 | 3 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-04 | 197 | 31 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | fc718a254bda4df2d62975d04393492fb75ab305 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 198 | 31 | 3 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.45e-04 | 198 | 31 | 3 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-04 | 198 | 31 | 3 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.45e-04 | 198 | 31 | 3 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.50e-04 | 199 | 31 | 3 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 199 | 31 | 3 | bb201deb281619113edcd1de2af2d3eb21b967b8 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-04 | 199 | 31 | 3 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.50e-04 | 199 | 31 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | lymphoid|World / Lineage, cell class and subclass | 3.50e-04 | 199 | 31 | 3 | bf599721e7109cf9f361e9381544c291920c28be | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 8f5d98f962ddd8c4658c89ff8a2894de1228562a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 345f1eac498cc87fd7bf08e7312608b2d6fe1dd7 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.55e-04 | 200 | 31 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Drug | glutamin | 1.39e-07 | 461 | 31 | 8 | CID000000738 | |
| Drug | stanolone benzoate | 5.38e-06 | 3 | 31 | 2 | ctd:C040109 | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 6.36e-06 | 196 | 31 | 5 | 1301_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; HL60; HG-U133A | 6.36e-06 | 196 | 31 | 5 | 1767_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; HL60; HG-U133A | 6.69e-06 | 198 | 31 | 5 | 1993_UP | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; HL60; HG-U133A | 6.85e-06 | 199 | 31 | 5 | 1559_DN | |
| Drug | Scytolone | 9.79e-05 | 11 | 31 | 2 | CID000162567 | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; HL60; HG-U133A | 1.07e-04 | 183 | 31 | 4 | 1590_UP | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A | 1.19e-04 | 188 | 31 | 4 | 1395_UP | |
| Drug | Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; HL60; HG-U133A | 1.29e-04 | 192 | 31 | 4 | 1616_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 193 | 31 | 4 | 4690_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.32e-04 | 193 | 31 | 4 | 4285_DN | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.34e-04 | 194 | 31 | 4 | 4470_DN | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A | 1.34e-04 | 194 | 31 | 4 | 1547_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.34e-04 | 194 | 31 | 4 | 1060_UP | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; HL60; HG-U133A | 1.37e-04 | 195 | 31 | 4 | 1754_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 1.40e-04 | 196 | 31 | 4 | 1558_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 2056_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A | 1.40e-04 | 196 | 31 | 4 | 1567_DN | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; HL60; HG-U133A | 1.40e-04 | 196 | 31 | 4 | 1570_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A | 1.40e-04 | 196 | 31 | 4 | 1367_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 5785_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; HL60; HG-U133A | 1.42e-04 | 197 | 31 | 4 | 2003_DN | |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | 1.42e-04 | 197 | 31 | 4 | 284_UP | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; HL60; HG-U133A | 1.42e-04 | 197 | 31 | 4 | 1787_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; PC3; HG-U133A | 1.42e-04 | 197 | 31 | 4 | 1933_UP | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; HL60; HG-U133A | 1.45e-04 | 198 | 31 | 4 | 1977_DN | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A | 1.45e-04 | 198 | 31 | 4 | 1761_DN | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; HL60; HG-U133A | 1.45e-04 | 198 | 31 | 4 | 1594_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 6976_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; HL60; HG-U133A | 1.45e-04 | 198 | 31 | 4 | 1390_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; PC3; HG-U133A | 1.45e-04 | 198 | 31 | 4 | 1955_UP | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 7173_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 2077_DN | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; HL60; HG-U133A | 1.48e-04 | 199 | 31 | 4 | 1989_UP | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A | 1.48e-04 | 199 | 31 | 4 | 1568_DN | |
| Drug | TTNPB; Down 200; 0.1uM; MCF7; HG-U133A | 1.48e-04 | 199 | 31 | 4 | 223_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; HL60; HG-U133A | 1.48e-04 | 199 | 31 | 4 | 1586_DN | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; HL60; HG-U133A | 1.48e-04 | 199 | 31 | 4 | 1973_UP | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; HL60; HG-U133A | 1.51e-04 | 200 | 31 | 4 | 1714_UP | |
| Disease | Adenoid Cystic Carcinoma | 6.40e-08 | 100 | 31 | 5 | C0010606 | |
| Disease | household income | 6.75e-07 | 304 | 31 | 6 | EFO_0009695 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 1.07e-06 | 2 | 31 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | chronotype measurement | 2.64e-06 | 882 | 31 | 8 | EFO_0008328 | |
| Disease | gastroesophageal reflux disease | 3.79e-06 | 101 | 31 | 4 | EFO_0003948 | |
| Disease | Alzheimer disease, educational attainment | 5.61e-06 | 247 | 31 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 6.40e-06 | 4 | 31 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 6.40e-06 | 4 | 31 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | age at first birth measurement | 7.52e-06 | 120 | 31 | 4 | EFO_0009101 | |
| Disease | Phyllodes Tumor | 1.07e-05 | 5 | 31 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 1.07e-05 | 5 | 31 | 2 | C0600066 | |
| Disease | neuroimaging measurement | 1.08e-05 | 1069 | 31 | 8 | EFO_0004346 | |
| Disease | Bladder Neoplasm | 1.38e-05 | 140 | 31 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.42e-05 | 141 | 31 | 4 | C0005684 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.58e-05 | 801 | 31 | 7 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | smoking status measurement | 1.96e-05 | 1160 | 31 | 8 | EFO_0006527 | |
| Disease | brain measurement, neuroimaging measurement | 2.02e-05 | 550 | 31 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.85e-05 | 346 | 31 | 5 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | risky sexual behaviour measurement | 2.90e-05 | 169 | 31 | 4 | EFO_0007877 | |
| Disease | Prostatic Neoplasms | 3.81e-05 | 616 | 31 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.81e-05 | 616 | 31 | 6 | C0376358 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 3.83e-05 | 9 | 31 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.06e-05 | 195 | 31 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | schizophrenia (is_implicated_in) | 7.57e-05 | 78 | 31 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 1.28e-04 | 93 | 31 | 3 | C1535926 | |
| Disease | Squamous cell carcinoma of esophagus | 1.36e-04 | 95 | 31 | 3 | C0279626 | |
| Disease | major depressive disorder (is_implicated_in) | 1.44e-04 | 17 | 31 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 1.81e-04 | 19 | 31 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | Schizophrenia | 2.74e-04 | 883 | 31 | 6 | C0036341 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 2.91e-04 | 24 | 31 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | congenital heart disease (is_implicated_in) | 2.91e-04 | 24 | 31 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | childhood trauma measurement | 2.91e-04 | 24 | 31 | 2 | EFO_0007979 | |
| Disease | smoking cessation | 3.59e-04 | 325 | 31 | 4 | EFO_0004319 | |
| Disease | Sezary Syndrome | 3.69e-04 | 27 | 31 | 2 | C0036920 | |
| Disease | cortical surface area measurement | 4.04e-04 | 1345 | 31 | 7 | EFO_0010736 | |
| Disease | hematocrit | 5.63e-04 | 1011 | 31 | 6 | EFO_0004348 | |
| Disease | Craniofacial Abnormalities | 5.84e-04 | 156 | 31 | 3 | C0376634 | |
| Disease | prostate cancer (is_marker_for) | 5.84e-04 | 156 | 31 | 3 | DOID:10283 (is_marker_for) | |
| Disease | Spinocerebellar Ataxia Type 2 | 5.87e-04 | 34 | 31 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 5.87e-04 | 34 | 31 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 5.87e-04 | 34 | 31 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 5.87e-04 | 34 | 31 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 5.87e-04 | 34 | 31 | 2 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 5.87e-04 | 34 | 31 | 2 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 6.22e-04 | 35 | 31 | 2 | C0752122 | |
| Disease | age at first sexual intercourse measurement | 6.66e-04 | 383 | 31 | 4 | EFO_0009749 | |
| Disease | diet measurement | 6.83e-04 | 1049 | 31 | 6 | EFO_0008111 | |
| Disease | chronic obstructive pulmonary disease | 6.98e-04 | 688 | 31 | 5 | EFO_0000341 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 7.69e-04 | 398 | 31 | 4 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | urinary albumin to creatinine ratio | 8.71e-04 | 179 | 31 | 3 | EFO_0007778 | |
| Disease | cortical thickness | 9.31e-04 | 1113 | 31 | 6 | EFO_0004840 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.03e-03 | 45 | 31 | 2 | DOID:3748 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEPLQQQQQQQQQQQ | 1 | Q8IVW6 | |
| QQQQQQQQQQKQPHL | 6 | Q8IVW6 | |
| QPGLSQQQQQQQQQH | 371 | Q4VCS5 | |
| CTAQQQQQQQQQQLP | 401 | Q9Y2K5 | |
| NQPQFQQMRQIIQQN | 281 | P54727 | |
| QQEQQQEQQQEQVQM | 376 | P06727 | |
| PQQIMQLQQQQQQQI | 421 | Q6ZW49 | |
| QQQQQQIQQQQLQRM | 526 | Q6ZW49 | |
| HQQQQQQQMQSQTAP | 541 | Q6ZW49 | |
| QTQQVQPQNLQMQQQ | 2381 | P46531 | |
| QMQQQNLQPANIQQQ | 2391 | P46531 | |
| QQQMGQVLQQQNIQQ | 3476 | Q8NEZ4 | |
| LMQQKQQQQQQQQQQ | 481 | Q96JK9 | |
| MSLKPQQQQQQQQQQ | 161 | Q99700 | |
| QQQQQQQQQQQHPGK | 181 | O15409 | |
| VFQQQLLQMQQLQQQ | 216 | O15409 | |
| QQQQALMLQQQQLQE | 131 | Q9H334 | |
| MQQQFQAVVQQQQQL | 196 | Q96RN5 | |
| AILPEQQQQQQQQQQ | 2046 | Q93074 | |
| LSNQQQQQQQQQQVM | 876 | O94916 | |
| MQSNSPSQEQQQQQQ | 1241 | O94916 | |
| AAARQQQQQQQQQQP | 26 | O15265 | |
| QLSLMQQQPQQQVQQ | 726 | O60741 | |
| QQQQQQQQQQQLQMP | 331 | Q8IWX8 | |
| TLPGLQQQQQQQQQQ | 211 | P51531 | |
| AQPQVQAEQQQQQMY | 1491 | P57071 | |
| QRQQEQMKQQQWQQQ | 676 | Q9Y520 | |
| QMKQQQWQQQQQQGV | 681 | Q9Y520 | |
| APTVVVQQQQQQQQQ | 491 | Q15714 | |
| QQQQQQQQQPALQGV | 501 | Q15714 | |
| PGALQQQHQQQQQQQ | 121 | P20265 | |
| VMQQQQQTTQQQLPQ | 116 | Q15459 | |
| QQMEQQQHGQNPQQA | 956 | Q92922 | |
| MFSQQQQQQLQQQQQ | 1 | Q9ULV3 | |
| GLNSWQQQQQQQQQP | 646 | Q9HBL0 | |
| QLMHQQQQLQPQQVQ | 151 | P0CG23 | |
| MNHQQQQQQQKAGEQ | 1 | Q93009 | |
| MVSALQQQQQQQQRQ | 1316 | Q9UPQ9 | |
| QQQQQQQQRQPGMKH | 1321 | Q9UPQ9 | |
| QRMQLAQKLQQQQQQ | 3726 | O14686 | |
| QQQQQQQQHQQQGSM | 3856 | O14686 | |
| FQQQQQQQQMGLLNQ | 3966 | O14686 |